Long-acting triptorelin for the treatment of endometriosis

International Journal of Gynecology and Obstetrics

Volumn 54, Issue 3, 1996, Pages 237-243

  Choktanasiri, W ^a   Boonkasemsanti, W ^b   Sittisomwong, T ^b   Kunathikom, S ^c   Suksompong, S ^c   Udomsubpayakul, U ^a   Rojanasakul, A ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Decapeptyl CR; Endometriosis; GnRH agonist; Triptorelin

Indexed keywords

CHOLESTEROL; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; HORMONE; LIPID; LUTEINIZING HORMONE; TRIACYLGLYCEROL; TRIPTORELIN;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIOSIS; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR NECK; FERTILITY; FOLLITROPIN BLOOD LEVEL; HEADACHE; HORMONE BLOOD LEVEL; HOT FLUSH; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LAPAROSCOPY; LIPID BLOOD LEVEL; LUMBAR VERTEBRA; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUATION; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RADIUS; STATISTICAL ANALYSIS; SWEATING; SYMPTOM; TRIACYLGLYCEROL BLOOD LEVEL; VAGINA DISEASE; VERTIGO;

EID: 0030248546     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/0020-7292(96)02698-7     Document Type: Article

References (19)

1. [1] Erickson LD, Ory SJ. GnRH analogues in the treatment of endometriosis. Obstet Gynecol Clin North Am 1989; 16: 123-143.
2. 6-luteinizing hormone-releasing hormone: long-term follow-up in a series of 50 patients. Fertil Steril 1990; 53: 401-406.
3. [3] Dlugi AM, Miller JD, Knittle J. Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo controlled, double blind study. Fertil Steril 1990; 54: 419-427.
4. [4] Shaw RW. Evaluation of treatment with gonadotrophin-releasing hormone analogues. In: Shaw RW, editor. Endometriosis, current understanding and management. Glasgow: Bell and Bain, 1995: 206-234.
5. [5] Meldrum DR, Chang RJ, Lu J, Vale W, Rivier J, Judd HL. Medical oophorectomy using a long-acting GnRH agonist: a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab 1982; 54: 1081-1083.
6. [6] American Fertility Society. Revised American Fertility Society classification of endometriosis. Fertil Steril 1985; 43: 351-352.
7. [7] Henzl MR, Corson SL, Moghissi K, Buttram VC, Berquist C, Jacobson J. Administration of nasal nafarelin as compared with oral danazol for endometriosis. N Engl J Med 1988; 318: 485-489.
8. [8] Shaw RW. An open randomised comparative study of the effect of goserelin and danazol in the treatment of endometriosis. Fertil Steril 1992; 58: 265-272.
9. [9] Ever JLH. The second look laparoscopy for evaluation of the result of medical treatment of endometriosis should not be performed during ovarian suppression. Fertil Steril 1987; 47: 520-523.
10. [10] Wright S, Valdes CT, Dunn RC, Franklin RR. Short-term Lupron and danazol therapy for pelvic endometriosis. Fertil Steril 1995; 63: 504-507.
11. [11] Donnez J, Nisolle M, Clerckx F. Evaluation of preoperative use of danazol, gestrinone, lynestrenol, buserelin spray and buserelin implant in the treatment of endometriosis associated infertility. In: Chandha DR, Buttram VC Jr, editors. Current concepts in endometriosis. New York: Liss, 1990: 357-382.
12. [12] Matta WH, Shaw RW, Hesp R, Katz D. Hypogonadism induced by luteinizing hormone-releasing hormone agonist analogues: effects on bone density in premenopausal women. Br Med J 1987; 294: 1523-1524.
13. [13] Uemura T, Suzuki N, Mohri J, Katagiri N, Osada H, Minaguchi H. Effect of gonadotropin-releasing hormone agonist on the bone mineral obesity of patients with endometriosis. Fertil Steril 1994; 62: 246-250.
14. [14] Waibel-Treber S, Minne HW, Scharla SH, Bremen TH, Ziegler RZ, Leyendecker GL. Reversible bone loss in women treated with GnRH agonist for endometriosis and uterine leiomyoma. Hum Reprod 1989; 4: 384-388.
15. [15] Dawood MY, Ramos J, Khan-Dawood F. Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin. Fertil Steril 1995; 63: 1177-1183.
16. [16] Surrey ES. Steroidal and nonsteroidal 'add-back' therapy: extending safety and efficacy of gonadotropin-releasing hormone agonists in the gynecologic patient. Fertil Steril 1995; 64: 474-481.
17. [17] Edmonds DK, Howell R. Can hormone replacement therapy be used during medical therapy of endometriosis? Br J Obstet Gynaecol 1994; 101 Suppl 10: 24-26.
18. [18] Lindsay P, Shaw RW. The effect of Livial on GnRH agonist induced bone loss [abstract]. 7th International Congress on the Menopause: 1993 June 20-24; Stockholm.
19. [19] Howell R, Edmonds DK, Dowsett M, Crook D, Lees B, Stevenson JC. Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial. Fertil Steril 1995; 64: 474-481.